Daniela Corno
speaker
97 appearances
1 recordings
1 series
first heard Jul 2026
last heard 8 Jul
Daniela Corno’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
Unpacking AMR · New Conceptions to Manage AMR – Part 4 – Collective Action Problems · 8 Jul 2026
podcast
Right now, fans across the world are cheering for their favorite FIFA World Cup team, and I can't help but think of AMR as a football game.
Eleven of the best players in the world won't win if they don't pass, hover for each other, and trust their teammates to be where they're needed.
One player out of position and the whole move falls apart.
Antimicrobial resistance can look a bit like that.
Countries and sectors have to coordinate, playing their roles and sticking to shared rules to protect the effectiveness of antibiotics.
But limited resources, competing interests, and unequal access make that cooperation difficult, and the consequences are global.
Welcome to another episode of Unpacking AMR, the podcast that unpacks the latest AMR policy research.
My name is Daniela Corno, and today we are bringing you our last episode of the New Conceptions of AMR miniseries.
This series has explored how AMR is more than just a biomedical problem.
It is also deeply interconnected with socio-ecological and structural issues.
We've looked at how antimicrobials act as a kind of invisible infrastructure woven into our everyday systems.
We've also explored the socio-ecological dynamics of AMR, or ways microbes in nature shape human lives through our daily activities, and the urban political ecologies, or how urbanization, the environment, and global health threats intersect, and how these relationships influence AMR.
Today, we turn to the last of these new conceptions: understanding AMR as a collective action problem, a global social challenge.
Challenge driven by different groups of people, each with their own competing interests and limited incentives to cooperate across borders.
I'll be joined by Dr.
Laura Valtere, postdoctoral fellow at the University of Copenhagen Center for Advanced Studies in Bioscience Innovation Law, and Dr.
Daniel Corelli, postdoctoral researcher at Traumers University of Technology in Sweden.
Together, they'll explore antimicrobial resistance through the lens of collective action and why solving it may be one of the hardest global governance challenges of our time.
You'll often hear AMR described as a weakest link problem.
It's a common framing in this field, but what does it actually mean?
Showing 1–20 of 97 · page 1 of 5
Next →